NYR 11.1% 5.6¢ nyrada inc.

Ann: European Patent to be Granted for Cholesterol-Lowering Drug, page-10

  1. 101 Posts.
    lightbulb Created with Sketch. 8
    Main reason for the overselling is due to the China lockdowns impacting the company contracted to produce the drug. Not a fundamental sell down in any way, just market sentiment. At the current price this is a screaming buy.
 
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
5.6¢
Change
-0.007(11.1%)
Mkt cap ! $10.20M
Open High Low Value Volume
6.3¢ 6.3¢ 5.6¢ $6.557K 112.2K

Buyers (Bids)

No. Vol. Price($)
2 159741 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 74205 1
View Market Depth
Last trade - 15.30pm 05/07/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.